NVS vs RGNX
NVS (NVS) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
NVS (NVS) common stock.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
NVS does not have a complete income-statement cache yet.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
NVS currently screens at market cap $0. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the NVS and RGNX stock pages for the full models.
Not investment advice.